NADPH oxidases (NOX): an overview from discovery, molecular mechanisms to physiology and pathology

A Vermot, I Petit-Härtlein, SME Smith, F Fieschi - Antioxidants, 2021 - mdpi.com
The reactive oxygen species (ROS)-producing enzyme NADPH oxidase (NOX) was first
identified in the membrane of phagocytic cells. For many years, its only known role was in …

[HTML][HTML] The role of NADPH oxidases in infectious and inflammatory diseases

JP Taylor, MT Hubert - Redox biology, 2021 - Elsevier
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOX) are enzymes that
generate superoxide or hydrogen peroxide from molecular oxygen utilizing NADPH as an …

Current strategies to combat cisplatin-induced ototoxicity

D Yu, J Gu, Y Chen, W Kang, X Wang… - Frontiers in …, 2020 - frontiersin.org
Cisplatin is widely used for the treatment of a number of solid malignant tumors. However,
ototoxicity induced by cisplatin is an obstacle to effective treatment of tumors. The basis for …

An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity

J Gu, X Wang, Y Chen, K Xu, D Yu, H Wu - Journal of Nanobiotechnology, 2022 - Springer
Background Excessive accumulation of reactive oxygen species (ROS) has been
documented as the crucial cellular mechanism of cisplatin-induced ototoxicity. However …

[图书][B] NOX inhibitors: from bench to naxibs to bedside

MH Elbatreek, H Mucke, HHHW Schmidt - 2021 - Springer
Reactive oxygen species (ROS) are ubiquitous metabolic products and important cellular
signaling molecules that contribute to several biological functions. Pathophysiology arises …

Adenosine A1 receptor protects against cisplatin ototoxicity by suppressing the NOX3/STAT1 inflammatory pathway in the cochlea

T Kaur, V Borse, S Sheth, K Sheehan… - Journal of …, 2016 - Soc Neuroscience
Cisplatin is a commonly used antineoplastic agent that produces ototoxicity that is mediated
in part by increasing levels of reactive oxygen species (ROS) via the NOX3 NADPH oxidase …

[HTML][HTML] Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation

VTV Dao, MH Elbatreek, S Altenhöfer, AI Casas… - Free Radical Biology …, 2020 - Elsevier
Dysfunctional reactive oxygen species (ROS) signaling is considered an important disease
mechanism. Therapeutically, non-selective scavenging of ROS by antioxidants, however …

Transient receptor potential (TRP) channels as molecular targets in lung toxicology and associated diseases

A Dietrich, D Steinritz, T Gudermann - Cell calcium, 2017 - Elsevier
The lungs as the gateways of our body to the external environment are essential for gas
exchange. They are also exposed to toxicants from two sides, the airways and the …

Genome-Wide Association Study Identifies Nox3 as a Critical Gene for Susceptibility to Noise-Induced Hearing Loss

J Lavinsky, AL Crow, C Pan, J Wang, KA Aaron… - PLoS …, 2015 - journals.plos.org
In the United States, roughly 10% of the population is exposed daily to hazardous levels of
noise in the workplace. Twin studies estimate heritability for noise-induced hearing loss …

Therapeutic potential of NOX inhibitors in neuropsychiatric disorders

P Kaur, H Khan, AK Grewal, K Dua, TG Singh - Psychopharmacology, 2023 - Springer
Rationale Neuropsychiatric disorders encompass a broad category of medical conditions
that include both neurology as well as psychiatry such as major depressive disorder, autism …